Fresenius Medical Care AG & Co. KGaA

    Fresenius Medical Care AG & Co. KGaA

    SSIX:FME
    - -
    CHF
    - -
    - -
    15.75P/E
    2013 Y
    2014 Y
    2015 Y
    2016 Y
    2017 Y
    2018 Y
    2019 Y
    2020 Y
    2021 Y
    2022 Y
    2023 Y
    2024 Y
    2025 Y
    TTM
    Revenue per Share
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    60.14
    66.15
    66.3
    65.9
    67.4
    51.95
    Basic EPS, GAAP
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    3.31
    2.3
    1.7
    1.83
    3.36
    2.57
    Free Cash Flow per Basic Share
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    5.58
    4.92
    6.63
    5.75
    6.06
    4.15
    Dividend per Share
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    1.34
    1.35
    1.12
    1.19
    1.45
    - -
    Book Value per Share
    22.18
    25.76
    29.62
    32.58
    32.04
    38.32
    40.08
    38.29
    43.34
    47.68
    46.42
    49.68
    47.66
    - -
    Tangible Book Value per Share
    -7.64
    -12.3
    -11.91
    -12.35
    -9.68
    -3.69
    -11.68
    -10.67
    -10.66
    -11.32
    -8.15
    -6.69
    -5.43
    - -
    Basic Weighted Avg Shares
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    293
    293
    293
    293
    291
    280
    Sales/Revenue/Turnover
    10,580
    13,019
    15,455
    16,570
    17,784
    16,547
    17,477
    17,859
    17,619
    19,398
    19,454
    19,336
    19,628
    14,567
    Operating Margin (%)
    15.26
    14.08
    13.59
    14.1
    12.76
    13.03
    12.56
    12.37
    10.55
    7.5
    7.59
    7.59
    9.31
    9.79
    Depreciation Expense
    469
    575
    648
    702
    735
    790
    1,593
    1,786
    1,624
    1,838
    1,752
    1,742
    1,500
    1,194
    Net Income, GAAP
    804
    860
    955
    1,144
    1,280
    1,982
    1,200
    1,164
    969
    673
    499
    538
    978
    719
    Effective Tax Rate (%)
    32.04
    31.66
    31.82
    30.58
    22.18
    18.67
    21.83
    25.85
    22.45
    26.65
    29.1
    29.9
    21.22
    20.06
    Profit Margin (%)
    7.6
    6.6
    6.18
    6.9
    7.2
    11.98
    6.86
    6.52
    5.5
    3.47
    2.57
    2.78
    4.98
    4.94
    Working Capital
    1,979
    2,665
    2,395
    1,585
    1,074
    1,579
    106
    1,219
    710
    1,736
    2,590
    2,263
    1,653
    - -
    LT Debt
    5,610
    7,413
    7,183
    6,833
    5,795
    5,046
    10,525
    10,683
    10,735
    11,176
    10,489
    9,761
    8,598
    - -
    Total Equity
    6,869
    8,247
    9,600
    11,051
    10,828
    12,902
    13,227
    12,331
    13,979
    15,449
    14,827
    15,769
    14,283
    - -
    Return on Invested Capital (%)
    8.24
    8.53
    8.45
    8.75
    9.36
    9.03
    7.19
    6.28
    5.49
    3.78
    3.73
    3.79
    5.49
    8.94
    Return on Capital (%)
    7.01
    6.63
    6.03
    6.35
    7.1
    10.86
    5.67
    4.63
    3.82
    2.56
    2.04
    2.31
    4.12
    6.1
    Return on Common Equity (%)
    11.96
    11.89
    11.36
    12.03
    12.93
    18.37
    10.12
    10.05
    8.11
    5.05
    3.61
    3.82
    7.02
    10.84

    Capital Structure

    EUR

    •

    in mil. unless spec.
    Dec'25
    Mar'26
    Jun'26
    ST Debt
    2,197
    2,389
    - -
    LT Borrowings
    5,692
    5,741
    - -
    LT Finance Leases
    2,906
    2,899
    - -
    Preferred Equity and Hybrid Capital
    - -
    - -
    - -
    Shares Outstanding
    279
    270
    270
    Market Capitalization
    - -
    - -
    10,916

    Working Capital

    EUR

    •

    in mil. unless spec.
    Dec'25
    Mar'26
    Jun'26
    Total Current Assets
    7,898
    8,108
    - -
    Cash, Cash Equivalents & STI
    1,821
    1,623
    - -
    Accounts Receivable, Net
    3,161
    3,582
    - -
    Inventories
    2,141
    2,303
    - -
    Total Current Liabilities
    6,245
    6,730
    - -
    Payables & Accruals
    1,378
    1,042
    - -
    ST Debt
    2,197
    2,389
    - -
    Deferred Revenue
    114
    - -
    - -

    Growth Rates

    EUR

    •

    in mil. unless spec.

    (avg. rate of change)

    10 years
    5 years
    1 year
    Total Equity
    4.48%
    3.36%
    -9.42%
    Free Cash Flow
    14.54%
    -6.84%
    4.67%
    Net Income, GAAP
    6.06%
    3.3%
    81.88%
    Sales/Revenue/Turnover
    2.53%
    1.99%
    1.51%
    Total Cash Common Dividend
    6.51%
    4.58%
    21.01%

    Quarterly Revenue

    EUR

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2024
    4,725
    4,766
    4,760
    5,085
    19,336
    2025
    4,881
    4,792
    4,885
    5,070
    19,628
    2026
    4,612
    - -
    - -
    - -
    - -

    Quarterly Earnings Per Share

    EUR

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2024
    0.24
    0.64
    0.73
    0.23
    1.83
    2025
    0.52
    0.77
    0.94
    1.14
    3.36
    2026
    0.43
    - -
    - -
    - -
    - -

    Quarterly Dividends Per Share

    EUR

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2024
    - -
    - -
    - -
    - -
    1.19
    2025
    - -
    - -
    - -
    - -
    1.45
    2026
    - -
    - -
    - -
    - -
    - -

    Company Description

    Company Profile APIChatGPT
    Address
    Similar Companies
    Business